BIO-BBIO-BNYSE

Revenue (LTM)

$2.6B

+0.7% YoY

Net Income (LTM)

$760M

+141.2% YoY

Free Cash Flow

$375M

Revenue CAGR (5Y)

+0.3%

Marginsdeclining

FCF$0.4B

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	2,923	2,802↓4.1%	2,671↓4.7%	2,567↓3.9%	2,583↑0.7%
Gross Profit	1,638	1,567↓4.3%	1,427↓9.0%	1,379↓3.4%	1,344↓2.6%
Operating Income	500	483↓3.5%	338↓30.0%	269↓20.4%	271↑0.6%
Net Income	4,254	-3,628↓185.3%	-637↑82.4%	-1,844↓189.4%	760↑141.2%
EBITDA	5,588	-4,489↓180.3%	-655↑85.4%	-2,142↓227.1%	476↑122.2%
EPS Diluted	140.83	-121.79↓186.5%	-21.82↑82.1%	-65.36↓199.5%	27.87↑142.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	471	434↓7.8%	404↓7.0%	488↑20.9%	532↑9.0%
Total Current Assets	1,990	3,158↑58.7%	3,048↓3.5%	3,030↓0.6%	2,906↓4.1%
Total Assets	17,799	13,502↓24.1%	12,299↓8.9%	9,364↓23.9%	10,577↑12.9%
Total Current Liabilities	681	569↓16.5%	523↓8.1%	468↓10.5%	517↑10.5%
Total Liabilities	4,114	3,886↓5.5%	3,558↓8.5%	2,795↓21.4%	3,123↑11.7%
Total Equity	13,685	9,615↓29.7%	8,741↓9.1%	6,569↓24.8%	7,454↑13.5%
Total Debt	223	1,388↑521.4%	1,406↑1.3%	1,375↓2.2%	1,531↑11.4%
Net Debt	-247	954↑485.6%	1,002↑5.0%	887↓11.5%	999↑12.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	669	194↓71.0%	375↑92.8%	455↑21.4%	532↑16.9%
Capital Expenditure	-134	-114↑14.6%	-157↓37.2%	-189↓20.6%	-158↑16.6%
Free Cash Flow	536	80↓85.0%	218↑171.8%	266↑22.0%	375↑40.7%
Stock-Based Comp	51	61↑18.9%	61↑0.7%	62↑1.6%	0
Net Change in Cash	-196	-37↑81.3%	-30↑17.5%	85↑383.0%	40↓52.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance